Breaking News

Adamis Prescription drugs Supplies Replace on Scientific Learn about Assessing Tempol for the Remedy of COVID-19

Adamis Prescription drugs Company Intervening time DSMB evaluate anticipated in overdue September SAN DIEGO, July 29, 2022 (GLOBE NEWSWIRE) — Adamis Prescription drugs Company (NASDAQ: ADMP) as of late equipped an replace at the Corporate’s ongoing U.S. Section 2/3 scientific trial to judge the protection and efficacy of Tempol as a remedy for COVID-19. The […]